In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Versartis, Inc.. Trade Record

NASDAQ:VSAR Versartis, Inc. stock gains 33.51% Exit Jun 20, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart VSAR Jun 5, 2018, priceSeries
About Versartis, Inc.

Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. The company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency. It develops drug candidates that it has licensed from Amunix Operating, Inc. The company was founded in 2008 and is headquartered in Menlo Park, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
90.38
Entry Date
Jun 5, 2018
Entry Price
1.65
Sell Date
Jun 20, 2018
Sell Price
2.20
Net Gain
33.51%
Hold Time
11 Trading Days